Common Stock, Shares, Outstanding of Adicet Bio, Inc. from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Adicet Bio, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2017 to 31 Dec 2025.
  • Adicet Bio, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 9,586,770, a 86% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Adicet Bio, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 9,586,770 +4,426,225 +86% 31 Dec 2025 10-K 12 Mar 2026 2025 FY
Q3 2025 83,253,779 +852,819 +1% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 83,252,520 +851,560 +1% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 82,709,625 +540,122 +0.66% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 5,160,545 -38,109,841 -88% 31 Dec 2024 10-K 12 Mar 2026 2025 FY
Q3 2024 82,400,960 +39,293,039 +91% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 82,400,960 +39,334,802 +91% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 82,169,503 +39,212,072 +91% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 43,270,386 +315,566 +0.74% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 43,107,921 +320,264 +0.75% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 43,066,158 +3,045,403 +7.6% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 42,957,431 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 42,954,820 +3,217,906 +8.1% 31 Dec 2022 10-K 19 Mar 2024 2023 FY
Q3 2022 42,787,657 +2,901,841 +7.3% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 40,020,755 +8,178,753 +26% 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q4 2021 39,736,914 0 0% 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 39,885,816 +20,296,179 +104% 30 Sep 2021 10-Q 12 May 2022 2022 Q1
Q2 2021 31,842,002 -4,602,730 -13% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 31,802,399 -4,642,333 -13% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 39,736,914 +37,581,336 +1743% 31 Dec 2020 10-Q 12 May 2022 2022 Q1
Q3 2020 19,589,637 -16,853,994 -46% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 36,444,732 +627,339 +1.8% 30 Jun 2020 10-Q 30 Jul 2020 2020 Q2
Q1 2020 36,444,732 +1,189,388 +3.4% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 2,155,578 -25,899,766 -92% 31 Dec 2019 10-K 12 Mar 2021 2020 FY
Q3 2019 36,443,631 +8,395,316 +30% 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 35,817,393 +7,769,078 +28% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 35,255,344 +7,209,029 +26% 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 28,055,344 +22,396,255 +396% 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q3 2018 28,048,315 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 28,048,315 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 28,046,315 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 5,659,089 31 Dec 2017 10-K 18 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.